BP
TEVA icon

Ballentine Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Ballentine Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,865
Closed -$262K – 404
2017
Q3 		$262K Sell
14,865
-2,889
-16% -$50.9K 0.01% 293
2017
Q2 		$582K Buy
+17,754
New +$582K 0.04% 177